Critical Contrast: Envoy Medical (COCH) versus Its Competitors

Envoy Medical (NASDAQ:COCH) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its competitors? We will compare Envoy Medical to similar companies based on the strength of its earnings, profitability, institutional ownership, dividends, risk, analyst recommendations and valuation.

Profitability

This table compares Envoy Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,026.41%	-5,250.23%	-112.19%
Envoy Medical Competitors	-303.57%	-175.14%	-22.20%

Valuation & Earnings

This table compares Envoy Medical and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Envoy Medical	$240,000.00	-$23.76 million	-1.48
Envoy Medical Competitors	$1.87 billion	$136.27 million	5.88

Envoy Medical’s competitors have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 7.2% of Envoy Medical shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations and price targets for Envoy Medical and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1	1	2	0	2.25
Envoy Medical Competitors	4291	10580	18367	831	2.46

Envoy Medical presently has a consensus target price of $21.00, indicating a potential upside of 208.37%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.34%. Given Envoy Medical’s higher possible upside, equities research analysts plainly believe Envoy Medical is more favorable than its competitors.

Volatility and Risk

Envoy Medical has a beta of 2.03, meaning that its share price is 103% more volatile than the S&P 500. Comparatively, Envoy Medical’s competitors have a beta of 2.57, meaning that their average share price is 157% more volatile than the S&P 500.

Summary

Envoy Medical competitors beat Envoy Medical on 12 of the 13 factors compared.

Envoy Medical Company Profile

Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with sensorineural hearing loss. Unlike conventional hearing aids and many cochlear implants, its technology is designed to be placed beneath the skin, with no external wearable sound processor. The company’s lead product is the Acclaim Cochlear Implant, a fully implanted cochlear implant intended to address moderate-to-profound sensorineural hearing loss in adults. The system is designed to use the body’s natural anatomy to capture sound and convert it into electrical signals that stimulate the auditory nerve.